Touchbio 3 Multi-drug Test (saliva) Pen - 1 Test
Couldn't load pickup availability
TouchBio 3 Multi-Drug Screening Test (Saliva) Pen – 1 Test
The TouchBio 3 Multi-Drug Screening Test (Saliva) Pen is a portable, non-invasive screening device designed to detect the presence of Marijuana (THC), Methamphetamine (MET), and MDMA (Ecstasy) in saliva samples. This user-friendly, pen-style device offers rapid screening results in approximately 3 minutes, making it suitable for workplace compliance programs, personal monitoring, and rehabilitation support applications. Compliant with Australian Standards AS/NZS 4760:2019, this screening tool delivers consistent, reliable results with a simple, mess-free collection method. The comprehensive three-drug panel screens for THC (15 ng/mL cut-off), Methamphetamine (50 ng/mL cut-off), and MDMA (50 ng/mL cut-off), providing clear, easy-to-interpret results. Designed for on-site or on-the-go use, the TouchBio 3 empowers employers, safety officers, and individuals to maintain workplace compliance and personal wellness monitoring efficiently and discreetly, all without the delays associated with laboratory-based testing.
- AS/NZS 4760:2019 Compliant: Meets Australian standards for saliva-based screening devices, ensuring legal defensibility and workplace compliance
- Rapid Screening Results: Clear results delivered in approximately 3 minutes
- Simple Saliva Collection: Non-invasive, pen-like design with mess-free sample collection via oral swabbing
- Three-Drug Panel: Screens for Marijuana (THC), Methamphetamine (MET), and MDMA with specified cut-off levels
- Discreet & Convenient: Designed for on-site, on-the-go screening in workplace and personal wellness settings
Directions for Use:
- Collect: Swab under the tongue and along gums approximately 10–15 times until oral fluid appears (approximately 60 seconds)
- Activate: Insert the swab into the pen housing and start timing
- Read: After 3 minutes (results remain valid up to 10 minutes), interpret the result: two lines indicate negative; one control line only indicates positive
- For detailed instructions, refer to the product Information for Use (IFU) documentation
Important Disclaimer: This screening device is intended solely for workplace screening, personal use, or adherence monitoring in drug rehabilitation programmes. This device is not intended for clinical diagnosis or medical purposes. Screening results should be used only for preliminary indication purposes and should not be relied upon as a definitive medical determination.
CPP